Abstract
During human development, stem cells establish themselves in specific anatomic locations or niches. The niche harbors the stem cells, and regulates how stem cells proliferate. The interaction between stem cells and their niche affects stem cell function, and offers an opportunity to improve the marrow microenvironment. Osteoblasts produce hematopoietic growth factors and are activated by parathyroid hormone (PTH). A calcium sensing receptor, expressed by hematopoietic stem cells, regulates the niche and can be targeted to increase stem cell numbers. Therefore, drugs that affect osteoblast function or target calcium receptors may be useful for stem cell mobilization and engraftment. In this review, the biology of the stem cell niche and the potential therapeutic manipulations of the stem cell niche are reviewed. PTH is in clinical trials for patients who have not mobilized autologous stem cells well. The limiting cell numbers for adult cord blood transplantation increase the risk of infection, and PTH is currently in a clinical trial following cord blood transplantation in an effort to improve engraftment and immune reconstitution.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Xie T, Spradling AC . A niche maintaining germ line stem cells in the Drosophila ovary. Science 2000; 290: 328–330.
Nilsson SK, Johnston HM, Coverdale JA . Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 2001; 97: 2293–2299.
Stier S, Ko Y, Forkert R, Lutz C, Neuhaus T, Grunewald E et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med 2005; 201: 1781–1791.
Nilsson SK, Johnston HM, Whitty GA, Williams B, Webb RJ, Denhardt DT et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 2005; 106: 1232–1239.
Adams GB, Chabner KT, Alley IR, Olson DP, Szczepiorkowski ZM, Poznasnsky MC et al. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 2006; 439: 599–603.
Lord BI . The architecture of bone marrow cell populations. Int J Cell Cloning 1990; 8: 317–331.
Taichman RS, Emerson SG . Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor. J Exp Med 1994; 179: 1677–1682.
Taichman RS, Reilly MJ, Emerson SG . Human osteoblasts support human hematopoietic progenitor cells in vitro bone marrow cultures. Blood 1996; 87: 518–524.
Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC et al. Osteoblastic cells regulate the hematopoietic stem cell niche. Nature 2003; 425: 841–846.
Calvi LM, Sims NA, Hunzelman JL, Knight MC, Giovannettti A, Saxton JM et al. Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J Clin Invest 2001; 107: 277–286.
Varnum-Finney B, Brashem-Stein C, Bernstein ID . Combined effects of Notch signaling and cytokines induce a multiple log increase in precursors with lymphoid and myeloid reconstituting ability. Blood 2003; 101: 1784–1789.
Lindsell CE, Shawber CJ, Boulter J, Weinmaster G . Jagged: a mammalian ligand that activates Notch1. Cell 1995; 80: 909–917.
Stier S, Cheng T, Dombkowski D, Carlesso N, Scadden DT . Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood 2002; 99: 2369–2378.
Christensen JL, Weissman IL . Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc Natl Acad Sci USA 2001; 98: 14541–14546.
Van Os R, Robinson S, Sheridan T, Mauch PM . Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal. Stem Cells 2000; 18: 120–127.
El-Badri NS, Wang BY, Cherry, Good RA . Osteoblasts promote engraftment of allogeneic hematopoietic stem cells. Exper Hematol 1998; 26: 110–116.
Reina E, Genrich K, Moadsiri A, Bartholomew A . Manipulation of the bone marrow microenvironment with low dose parathyroid hormone pulse therapy increases hematopoietic stem cell engraftment in non-human primates. World Transplant Congress 2006; 455a.
Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM . The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 2003; 349: 1216–1226.
Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 2003; 349: 1207–1215.
Robinson JA, Susulic B, Liu YP, Taylor C, Hardenburg J, Gironda V et al. Identification of a PTH regulated gene selectively induced in vivo during PTH-mediated bone formation. J Cell Biochem 2006; 98: 1203–1220.
Crandall C . Parathyroid hormone for the treatment of osteoporosis. Arch Intern Med 2002; 162: 2297–2309.
Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344: 1434–1441.
McClung M . Parathyroid for the treatment of osteoporosis. Obstet Gynecol Survey 2004; 59: 826–832.
Vose JM, Sharp G, Chan WC, Nichols C, Loh K, Inwards D et al. Autologous transplantation for aggressive non-Hodgkins's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease. J Clin Oncol 2002; 20: 2344–2352.
Fu P, Bagai RK, Meyerson H, Kane D, Fox RM, Creger RJ et al. Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization. Bone Marrow Transplant 2006; 38: 189–196.
Carlo-Stella C, Di Nicola M, Milani R, Guidetti A, Magni M, Milanesi M et al. Use of granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers. Blood 2004; 104: 3287–3295.
Goterris R, Hernandez-Boluda JC, Teruel A, Gomez C, Lis MJ, Terol MJ et al. Impact of different strategies of second-line stem cell harvest on the outcomes of autologous transplantation in poor peripheral blood stem cell mobilizers. Bone Marrow Transplant 2005; 36: 847–853.
Devine SM, Flomenberg N, Vesole DH, Liesveld J, Weisdorf D, Badel K et al. Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD 3100 to patients with multiple myeloma and non Hodgkin's lymphoma. J Clin Oncol 2004; 22: 1095–1102.
Ballen KK, Shpall EJ, Avigan D, Yeap B, McAfee S, Dey BR et al. Parathyroid hormone may improve autologous stem cell mobilization via the stem cell niche. Blood 2005; 106: 1968a.
Ballen KK . New trends in umbilical cord blood transplantation. Blood 2005; 105: 3786–3792.
Barker JN, Krepski TP, DeFor TE, Davies SM, Wagner JE, Weisdorf D . Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood vs bone marrow. Biol Blood Marrow Transplant 2002; 8: 251–260.
Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265–2275.
Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE . Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood after reduced intensity conditioning. Blood 2003; 105: 1343–1347.
Barker JN, Weisdorf DJ, Defor TE, Blazar BR, McGlave PB, Miller JS et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005; 105: 1343–1347.
Ballen KK, Spitzer TR, Yeap B, McAfee S, Dey BR, Attar E et al. Double unrelated reduced intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant 2007; 13: 82–89.
Ma N, Stamm C, Kaminski A, Li W, Kleine HD, Muller-Hilke B et al. Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc Res 2005; 66: 45–54.
Vendrame M, Cassady J, Newcomb J, Butler T, Pennypacker KR, Zigova T et al. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 2004; 35: 2390–2395.
Hackney JA, Charbord P, Brunk BP, Stoeckert CJ, Lemischka IR, Moore KA . A molecular profile of a hematopoietic stem cell niche. Proc Natl Acad Sci USA 2002; 99: 13061–13066.
Koch H, Jadlowiec JA, Campbell PG . Insulin-like growth factor I induces early osteoblasts gene expression in human mesenchymal stem cells. Stem Cells Dev 2005; 14: 621–631.
Sammons J, Ahmed N, El-Sheemy M, Hassan HT . The role of BMP-6, IL-6, and BMP-4 in mesenchymal stem cell-dependent bone development: effects on osteoblastic differentiation induced by parathyroid hormone and vitamin D(3). Stem Cells Dev 2004; 13: 273–280.
Acknowledgements
I thank Dr Gregor Adams for preparation of figures and Drs Joseph Antin, Henry Kronenberg, David Scadden and Thomas Spitzer for helpful discussions and critical review of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ballen, K. Targeting the stem cell niche: squeezing blood from bones. Bone Marrow Transplant 39, 655–660 (2007). https://doi.org/10.1038/sj.bmt.1705651
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705651
Keywords
This article is cited by
-
New understanding and treatments for osteoporosis
Endocrine (2012)
-
Teriparatide increases the maturation of circulating osteoblast precursors
Osteoporosis International (2012)
-
Cell biology of osteoimmunology
Wiener Medizinische Wochenschrift (2010)
-
Nephrogene systemische Fibrose
Medizinische Klinik (2009)
-
Cord Blood—An Alternative Source for Bone Regeneration
Stem Cell Reviews and Reports (2009)